Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Translation01:31

Translation

14.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
14.7K
Mutations01:39

Mutations

81.4K
Overview
81.4K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Incomplete Dominance01:43

Incomplete Dominance

22.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
22.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term B-cell depletion with rituximab in relapsing, refractory and severe lupus nephritis: a retrospective case series.

Clinical kidney journal·2026
Same author

Text Messaging for Longitudinal Data Collection From Adults With Glomerular Disease: Lessons From the Cure Glomerulonephropathy Network.

Kidney medicine·2026
Same author

Is It Time to Change Our Approach to Childhood Lupus Nephritis?

Journal of the American Society of Nephrology : JASN·2026
Same author

From Clot Prevention to Kidney Injury: Revisiting Anticoagulant-Related Nephropathy.

Kidney & blood pressure research·2026
Same author

Recessive variants in the intergenic NOS1AP-C1orf226 locus cause monogenic kidney disease responsive to anti-proteinuric treatment.

Nature communications·2025
Same author

Should Histology Guide Treatment Decisions in IgA Nephropathy?

Kidney international reports·2025
Same journal

Fabry Disease: Current Perspectives on Diagnosis and Management Strategies.

Advances in kidney disease and health·2026
Same journal

After the Diagnosis.

Advances in kidney disease and health·2026
Same journal

Collagen Genes-Related Glomerular Disease.

Advances in kidney disease and health·2026
Same journal

Genetic Nephrotic Syndrome in Children and Adolescents: An Update.

Advances in kidney disease and health·2026
Same journal

Incorporating Genetics Into Nephrology Practice-The New National Kidney Foundation Guidelines for Genetic Testing.

Advances in kidney disease and health·2026
Same journal

Genetic and Clinical Evaluation of Pediatric Cystic Kidney Diseases: Autosomal Dominant and Autosomal Recessive Polycystic Kidney Disease.

Advances in kidney disease and health·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K

Minimal Change Disease.

Alexis C Gomez1, Keisha L Gibson2, Harish Seethapathy1

  • 1Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Advances in Kidney Disease and Health
|July 31, 2024
PubMed
Summary
This summary is machine-generated.

Minimal change disease, a common cause of nephrotic syndrome, is better understood with new discoveries like antinephrin antibodies. This review covers its pathophysiology, treatment, and prognosis in children and adults.

Keywords:
Minimal change diseaseNephrotic syndromeSteroid sensitive

More Related Videos

Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

41.6K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.1K

Related Experiment Videos

Last Updated: Jun 18, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

33.7K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

41.6K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.1K

Area of Science:

  • Nephrology
  • Immunology
  • Pediatric Nephrology

Background:

  • Minimal change disease is a frequent cause of nephrotic syndrome in pediatric and adult populations.
  • Recent research has significantly advanced the understanding of its underlying pathophysiology.
  • Antinephrin antibodies have emerged as a potential diagnostic marker.

Purpose of the Study:

  • To review the current knowledge on the pathophysiology, treatment, and prognosis of minimal change disease.
  • To highlight differences in disease presentation and management between pediatric and adult patients.
  • To discuss recent advancements and their implications for future treatment strategies.

Main Methods:

  • Literature review of recent advancements in minimal change disease research.
  • Synthesis of existing data on pathophysiology, clinical presentation, and treatment outcomes.
  • Comparative analysis of pediatric versus adult patient populations.

Main Results:

  • Identification of antinephrin antibodies as a key diagnostic marker.
  • Elucidation of novel pathophysiological mechanisms contributing to the disease.
  • Established differences in disease course and response to treatment between age groups.

Conclusions:

  • Advances in understanding minimal change disease pathophysiology, including antinephrin antibodies, are transforming diagnostic and therapeutic approaches.
  • Tailored treatment strategies considering age-specific differences are crucial for optimal outcomes.
  • Further research is needed to fully elucidate disease mechanisms and refine treatment protocols.